Search

Your search keyword '"Rizvi, H. A."' showing total 326 results

Search Constraints

Start Over You searched for: Author "Rizvi, H. A." Remove constraint Author: "Rizvi, H. A."
326 results on '"Rizvi, H. A."'

Search Results

5. COVID-19 in patients with lung cancer

7. Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

9. EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

11. Cephalometric Study of the Dentofacial Complex of Bangladeshis according to Downs Analysis.

12. P2.07-03 Factors Associated with Disease Progression after Discontinuation of Immunotherapy for Immune-Related Toxicity in Non-small Cell Lung Cancer

18. On the nonlinear dynamics of large scale dust-acoustic solitary waves in a superthermal bi-ion dusty ionospheric magnetoplasma.

19. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

30. P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status

31. B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure.

36. A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer

40. Measurement of cross sections and leptonic forward-backward asymmetries at theZ pole and determination of electroweak parameters

41. Search for non-minimal Higgs bosons inZ 0 decays

42. Studies of hadronic event structure and comparisons with QCD models at theZ 0 resonance

43. Measurement of electroweak parameters from hadronic and leptonic decays of theZ 0

45. MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC

46. MA11.01 Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer

47. P1.14-06 Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers

48. MA07.02 Early Change of dNLR Is Correlated with Outcomes in Advanced NSCLC Patients Treated with Immunotherapy

Catalog

Books, media, physical & digital resources